Let's have a look at the most active stocks in today's session.
Top most active stocks
| Ticker | Change | Comment |
|---|---|---|
| FAMI | -50.35% | 239.64M shares of Farmmi Inc (NASDAQ:FAMI) have been traded so far today. Leading to a price decrease of 50.35%. A press release (Farmmi, Inc. Prices $81 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares) was released earlier today. |
| ATER | 41.65% | Aterian Inc's (NASDAQ:ATER) traded a high volume of 177.14M shares. The share price increased by 41.65%. |
| CEI | -6.57% | So far 137.86M shares of Camber Energy Inc (NYSEARCA:CEI) have traded in today's session. NYSEARCA:CEI is declining 6.57% today. |
| AAPL | 0.02% | 64.2M shares of Apple Inc (NASDAQ:AAPL) exchanged hands today. Shares are rising by 0.02%. A press release (Mobile Application Market To Expand Speedily With CAGR of 11.5% By 2027 Due To Rising Adoption of Internet And Smartphones To Carry Out Daily Activities | Million Insights) was released earlier today. |
| OCGN | 19.86% | 59.04M shares of Ocugen Inc (NASDAQ:OCGN) have been traded so far today. NASDAQ:OCGN is advancing 19.86% today. |
| SNDL | 4.04% | 57.76M shares of Sundial Growers Inc (NASDAQ:SNDL) have been traded so far today. The share price increased by 4.04%. |
| GSAT | -13.76% | 57.34M shares of Globalstar (NYSEARCA:GSAT) have been traded so far today. NYSEARCA:GSAT is declining 13.76% today. |
| AMC | 5.14% | 55.68M shares of AMC Entertainment Holdings Inc (NYSE:AMC) exchanged hands today. NYSE:AMC is advancing 5.14% today. |
| LPTX | 23.25% | 53.35M shares of Leap Therapeutics Inc (NASDAQ:LPTX) have been traded so far today. Leading to a price increase of 23.25%. A press release (Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress) was released yesterday. |
| LIFE | 45.07% | So far 50.34M shares of Atyr Pharma Inc (NASDAQ:LIFE) have traded in today's session. NASDAQ:LIFE is advancing 45.07% today. Earlier today the company had a press release: aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis. |
Our most active stocks screener will show you the full list.